Experience

Self-employed
• Real Estate
• 1 - 100 Employee
• Consultant Biomedical scientist/semi retired

  • 2018 - Present


University of Plymouth

• Higher Education

• Head of School, Biomedical and Biological Sciences

  • 2010 - 2015

  Head of School of Biomedical and Biological Sciences Lead a school with almost 1200 undergraduate students, 100 staff and almost 50 postgraduate students. Have direct responsibility for an annual budget of £7.2 million. Degree programmes have been redesigned and have successfully obtained accreditation from medical education England (BSc Healthcare Science awards, May 2011) and for our BSc Biomedical Science awards we are seeking validation from the IBMS (October 2011) for our September… Show more Head of School of Biomedical and Biological Sciences Lead a school with almost 1200 undergraduate students, 100 staff and almost 50 postgraduate students. Have direct responsibility for an annual budget of £7.2 million. Degree programmes have been redesigned and have successfully obtained accreditation from medical education England (BSc Healthcare Science awards, May 2011) and for our BSc Biomedical Science awards we are seeking validation from the IBMS (October 2011) for our September intake. Have Line management responsibility for three University Research Centres which are housed in the school: Centre for Research in Translational Biomedicine (CRTB) http://www.plymouth.ac.uk/pages/view.asp?page=34429 Ecotoxicology Research and Innovation Centre (ERIC) http://www.plymouth.ac.uk/research/eric Centre for Agricultural and Rural Sustainability (CARS) http://www.plymouth.ac.uk/researchcover/rcp.asp?page=395&pagetype=G The University is investing substantially in post-genomics equipment which will be housed within the school. This is in excess of £3 million and will bring next-generation DNA sequencing, proteomics and microfluidic based PCR into a purpose build facility which will be used extensively by researchers in the school and collaborators at the Peninsula College of Medicine and Dentistry. The school has recently been awarded funding by the MRC, Wellcome Trust, BBSRC, NERC, The Leverhulme trust, EC FP7, NIHR and from commercial sources.

• Associate Dean, Commercialisation, Faculty of Science and Technology

  • 2010 - 2013

  Faculty of Science and Technology Leading the commercialisation of the faculties research in the development of spin-out companies and licensing in conjunction with the Tamar Science park. Working as an academic advisor with a large Venture capital group that has previously developed a number of spin out companies with UK Universities. We have triaged a number of projects within the faculty and will yield commercial outcomes with academic involvement in the next two years.

• Professor of Molecular Diagnostics and Transfusion Medicine

  • 2009 - Present

  Set up the University research centre, Centre for Research in Translational Biomedicine



University of the West of England

• United Kingdom
• Higher Education
• 700 & Above Employee

• Professor of Molecular Biomedicine

  • 1999 - 2009

  Director, Centre for Research in Biomedicine Co-Director Bristol Genomics Research Institute Established the Centre for Research in Biomedicine (CRIB) at UWE in 2000 with Prof Wendy Purcell (now VC at Plymouth), Roger Hurst, Chris Pallister and Julie McLeod. Academics in CRIB returned the best performance at UWE in RAE 2008 with 15% 4*, 50% 3*, 25% 2*, 10% 1*. Set up a post-genomics facility (Bristol Genomics Research Institute) at UWE with Prof Steve Neill that included DNA… Show more Director, Centre for Research in Biomedicine Co-Director Bristol Genomics Research Institute Established the Centre for Research in Biomedicine (CRIB) at UWE in 2000 with Prof Wendy Purcell (now VC at Plymouth), Roger Hurst, Chris Pallister and Julie McLeod. Academics in CRIB returned the best performance at UWE in RAE 2008 with 15% 4*, 50% 3*, 25% 2*, 10% 1*. Set up a post-genomics facility (Bristol Genomics Research Institute) at UWE with Prof Steve Neill that included DNA array analysis and a proteomics suite, opened in 2003 via the SRIF initiatives. Led the following taught modules Transfusion & Transplantation Science, Immunology & Disease, MSc Haematology, MSc Research project. Research for my group here was funded in excess of £1.5 million from the BBSRC, NHS R&D directive, EC FP5 and 6, and the National Blood Service. Show less Director, Centre for Research in Biomedicine Co-Director Bristol Genomics Research Institute Established the Centre for Research in Biomedicine (CRIB) at UWE in 2000 with Prof Wendy Purcell (now VC at Plymouth), Roger Hurst, Chris Pallister and Julie McLeod. Academics in CRIB returned the best performance at UWE in RAE 2008 with 15% 4*, 50% 3*, 25% 2*, 10% 1*. Set up a post-genomics facility (Bristol Genomics Research Institute) at UWE with Prof Steve Neill that included DNA… Show more Director, Centre for Research in Biomedicine Co-Director Bristol Genomics Research Institute Established the Centre for Research in Biomedicine (CRIB) at UWE in 2000 with Prof Wendy Purcell (now VC at Plymouth), Roger Hurst, Chris Pallister and Julie McLeod. Academics in CRIB returned the best performance at UWE in RAE 2008 with 15% 4*, 50% 3*, 25% 2*, 10% 1*. Set up a post-genomics facility (Bristol Genomics Research Institute) at UWE with Prof Steve Neill that included DNA array analysis and a proteomics suite, opened in 2003 via the SRIF initiatives. Led the following taught modules Transfusion & Transplantation Science, Immunology & Disease, MSc Haematology, MSc Research project. Research for my group here was funded in excess of £1.5 million from the BBSRC, NHS R&D directive, EC FP5 and 6, and the National Blood Service. Show less



National Blood Service

• Hospitals and Health Care
• 100 - 200 Employee

• Section leader, Molecular diagnostics

  • 1990 - 1999

  Led a small group that defined the molecular basis of blood group antigens, and developed a National fetal blood group genotyping service for the clinical management of haemolytic disease of the fetus and newborn. Initially launched in 1995 by analysis of amniotic fluid samples, this migrated to using maternal plasma thus eliminating risky amniocentesis for this vulnerable patient group. This was achieved after obtaining research funding from the NHS R&D directive (1997-1999) and culminated in… Show more Led a small group that defined the molecular basis of blood group antigens, and developed a National fetal blood group genotyping service for the clinical management of haemolytic disease of the fetus and newborn. Initially launched in 1995 by analysis of amniotic fluid samples, this migrated to using maternal plasma thus eliminating risky amniocentesis for this vulnerable patient group. This was achieved after obtaining research funding from the NHS R&D directive (1997-1999) and culminated in the launch of the world's first non-invasive prenatal diagnosis service in 2001 after my departure. Show less Led a small group that defined the molecular basis of blood group antigens, and developed a National fetal blood group genotyping service for the clinical management of haemolytic disease of the fetus and newborn. Initially launched in 1995 by analysis of amniotic fluid samples, this migrated to using maternal plasma thus eliminating risky amniocentesis for this vulnerable patient group. This was achieved after obtaining research funding from the NHS R&D directive (1997-1999) and culminated in… Show more Led a small group that defined the molecular basis of blood group antigens, and developed a National fetal blood group genotyping service for the clinical management of haemolytic disease of the fetus and newborn. Initially launched in 1995 by analysis of amniotic fluid samples, this migrated to using maternal plasma thus eliminating risky amniocentesis for this vulnerable patient group. This was achieved after obtaining research funding from the NHS R&D directive (1997-1999) and culminated in the launch of the world's first non-invasive prenatal diagnosis service in 2001 after my departure. Show less



East Carolina University

• United States
• Higher Education
• 700 & Above Employee

• Special Research Fellow

  • 1982 - 1984

  Worked in the lab of the late Henry O Stone Jr on the molecular characterisation of Newcastle Disease virus, an avian paramyxovirus - similar to bird flu. Also spent some time in the lab of Dr Uwe Mueller working on the genetic manipulation of bacteriophage phiX174. Worked in the lab of the late Henry O Stone Jr on the molecular characterisation of Newcastle Disease virus, an avian paramyxovirus - similar to bird flu. Also spent some time in the lab of Dr Uwe Mueller working on the genetic manipulation of bacteriophage phiX174.